Skip to main content
. 2022 Jan 12;20:7. doi: 10.1186/s12964-021-00760-9

Fig. 8.

Fig. 8

Inhibiting PI3K-Akt pathway in glioblastoma-derived EVs-treated mNPCs reversed elevated NPC migration. A Wortamnnin significantly reversed U87-EVs-elevated migration cell numbers in U87-EVs-treated mNPCs in the transwell assay. B Wortamnnin significantly reversed U87-EVs-elevated relative width of scratch in U87-EVs-treated mNPCs in wound healing assay. Results are presented as the mean ± SD of three independent experiments. *p < 0.05, ***p < 0.001. Scale bar, 100 μm (A) and 200 μm (B)